Mark Jones, PhD, Head of Project Management at Basilea Pharmaceutica
joined us for World Anti-Microbial Resistance Congress USA 2015 to discuss
'navigating regulatory perspectives
'.
In this presentation learn about
navigating regulatory perspectives in the context of the unmet medical need for new antifungals
.
Download the presentation to understand more about:
-
Where will our new antifungals come from?
-
The net present value (NPV) of a typical antimicrobial
-
Incentives for making drug development more attractive
...and
much
more!
Get your copy here!
To learn more about
regulatory perspectives and unmet medical needs for new antimicrobials
, join us at
World Anti-Microbial Resistance Congress USA 2016
held
September 8-9
in
Washington, DC
.